viTToria biotherapeutics
0 followers
‌
Vittoria Biotherapeutics develops gene-edited cell therapies. they provide next-generation, paradigm-shifting T-cell therapeutics that address unmet medical needs. Senza5 Technology from viTToria improves the efficacy, safety, and utility of cell-based treatments in preclinical settings.
Industries
+1
Employees
Links
Org chart
Nicholas Siciliano
CEO, Co-Founder & Director
Nicholas Siciliano
Collapse
Rosemary Mazanet
Chief Medical Officer
Adam Snook
Head, Preclinical Development
Aditya Nimmagadda
Senior Director, CMC
Steven Yang
Director, Laboratory Operations
Lori Forrest
Senior Controller
Keith Westby
Chief Operating Officer
Jay Mohr
Board Observer
